2006
DOI: 10.1016/j.healthpol.2005.07.022
|View full text |Cite
|
Sign up to set email alerts
|

South Asian participation in clinical trials: The views of lay people and health professionals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
83
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 71 publications
(86 citation statements)
references
References 26 publications
2
83
0
Order By: Relevance
“…Similarly in the UK, The Race Relations Amendment Act (2000) and the NHS strategy to address inequalities (2000) have raised the bar for clinical trials enrollment of ethnic minorities, (e.g. South Asians who currently make up 4% of the UK population) who are under-represented in clinical trials (Hussain-Gambles et al 2006). For more than a decade, researchers in the US have been struggling to identify and overcome a wide range of barriers to minority accrual.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly in the UK, The Race Relations Amendment Act (2000) and the NHS strategy to address inequalities (2000) have raised the bar for clinical trials enrollment of ethnic minorities, (e.g. South Asians who currently make up 4% of the UK population) who are under-represented in clinical trials (Hussain-Gambles et al 2006). For more than a decade, researchers in the US have been struggling to identify and overcome a wide range of barriers to minority accrual.…”
Section: Introductionmentioning
confidence: 99%
“…While the literature on ethnic minority recruitment is predominantly focused on the US, similar barriers have been raised in the UK (Jolly et al 2005;Hussain-Gambles et al 2006;McDaid 2006), and it is likely that these issues are relevant in other countries with increasingly diverse populations and persistent health disparities (e.g. in European and South American countries).…”
Section: Introductionmentioning
confidence: 99%
“…Even when interpreters are available, patients with limited English proficiency may not be offered trials due to the logistical challenges of explaining trials to patients via an interpreter in a limited time period. 24,25 Clinicians may also worry about how well trained interpreters are to discuss clinical trials and the ramifications of inaccuracies in interpretation for achieving informed consent. 24,26 Clinicians' concerns about CALD patients with limited English proficiency struggling to understand trials are not unreasonable given that many English-speaking patients find trial information difficult to comprehend.…”
Section: Barriers To Trial Participationmentioning
confidence: 99%
“…24,25 Clinicians may also worry about how well trained interpreters are to discuss clinical trials and the ramifications of inaccuracies in interpretation for achieving informed consent. 24,26 Clinicians' concerns about CALD patients with limited English proficiency struggling to understand trials are not unreasonable given that many English-speaking patients find trial information difficult to comprehend. 27,28 Data regarding the use of interpreters or bilingual family members to explain trials was unavailable in this instance, but may be worth examining in future studies, along with levels of understanding among both interpreters and patients.…”
Section: Barriers To Trial Participationmentioning
confidence: 99%
“…5 This often inadvertent exclusion has serious implications for medical science by limiting validity and generalisability 6 and for social justice by affecting the allocation of resources for services and research. Research involving minority ethnic groups is also relevant to the majority 'white' population, as it increases understanding of the aetiology and management of long-term conditions;…”
Section: The Need For Addressing the Under-representation Of Minoritymentioning
confidence: 99%